Cantor Fitzgerald Weighs in on Merck & Co., Inc.'s FY2024 Ea

Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities researchers at Cantor Fitzgerald lifted their FY2024 EPS estimates for Merck & Co., Inc. in a research report issued to clients and investors on Friday, April 26th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn $8.53 per share for the year, […]

Related Keywords

Colorado , United States , Wellington , New Zealand General , New Zealand , Joseph Romanelli , Steven Mizell , Societe Generale , Gardasil , Merck Co Inc , Institutional Trading Of Merck Co Inc , Public Employees Retirement Association Of Colorado , Animal Health , Charles Schwab Investment Management Inc , Wellington Management Group , News Ratings For Merck Co , Cantor Fitzgerald , Securities Exchange Commission , Berenberg Bank , Wells Fargo Company , Norges Bank , Merck Co , Free Report , Get Free Report , Management Group , Schwab Investment Management , Nova Scotia , Public Employees Retirement Association , Employees Retirement Association , Exchange Commission , Live Oral , Nyse Mrk , Mrk , Medical , 58933y10 , Earnings Estimates ,